Active	Status	Sponsor type	Region	Phase	Filter
11 Active 36 Inactive 47 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ho, Allen
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)	Active, not recruiting	2/3	75	US	Valeda Light Delivery System	LumiThera, Inc., National Eye Institute (NEI)	Dry Age-related Macular Degeneration	05/25	06/25
Regillo, Carl
NCT05409235: Nesvategrast (OTT166) in Diabetic Retinopathy (DR)	Completed	2	225	US	OTT166, Vehicle control	OcuTerra Therapeutics, Inc., Parexel	Diabetic Retinopathy	12/23	12/23
Pitcher, John
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema	Recruiting	2	150	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin, Inc.	Diabetic Macular Edema (DME)	11/25	12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration	Recruiting	2	180	Japan, US, RoW	KHK4951, Aflibercept Injection	Kyowa Kirin, Inc.	Neovascular Age-Related Macular Degeneration (nAMD)	11/25	12/25
Formoso, Michele
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)	Active, not recruiting	2/3	75	US	Valeda Light Delivery System	LumiThera, Inc., National Eye Institute (NEI)	Dry Age-related Macular Degeneration	05/25	06/25